Fit to ScaleBook a call

Fit to Scale · GTM for founder-led B2B SaaS

Find the GTM bottleneck before you spend more on sales, ads, or hiring.

You know something is off. The expensive move is to throw budget at it before you know what 'it' is.

Most GTM spend treats symptoms. A diagnosis finds the constraint — the one misaligned lever that's capping the rest. Fit to Scale runs a structured analysis of where your pipeline actually breaks, so the next euro you spend lands on the real problem.

Book a GTM diagnosis

Something's wrong, but the data doesn't point at one thing.

  • Pipeline is inconsistent — good months, bad months, no clear reason.
  • Deals stall mid-evaluation with no obvious blocker.
  • ICP feels fuzzy; 'everyone could use this'.
  • The message lands with some buyers and bounces off others.
  • You're tempted to spend more on ads or a hire — without knowing it'll move anything.

Activity problems are usually alignment problems in disguise.

When 'qualified' deals stall late, a business case entered the pipeline that was never real. When evaluations drag, the MVP isn't delivering the expected outcome. When pricing becomes the topic, the value chain isn't clear. Each symptom traces back to a specific lever.

A diagnosis isolates the binding constraint instead of optimising six things at once and changing nothing.

We pressure-test all six levers — and name the one that's capping you.

The audit examines each, then ranks them by impact:

01

ICP & positioning

Is the target precise enough to win?

02

MVP & clear use case

Does the product deliver the outcome buyers expect?

03

Business case & value proposition

Is the ROI real and defensible?

04

Qualification

Are real deals being separated from polite interest?

05

Pricing logic

Does price map to value, or invite negotiation?

06

Sales narrative

Can the story be told without the founder?

Diagnosis before action is how a stalled, three-product team became a focused company with secured investment and closed ARR.

CS-IAI / SaaS / Media

Situation. Post-crisis team running three products across B2C and B2B; founder-driven, opportunistic sales; no clear ICP or value proposition.

Move. We defined a sharp ICP, shut down the B2C line, and merged two products into one focused offering.

Result. €2.5M new investment secured, merger with a competitor, €2M pipeline generated, €600K ARR closed.

CS-IISaaS / Health Tech

Situation. Founder-led selling proved strong demand, but the hired sales team couldn't convert — active pipeline, no closes, no structure or tracking.

Move. We located the pipeline breakpoints, rebuilt the sales narrative around clear ROI, and installed structured targets and tracking.

Result. From zero to multiple closed deals in 3 months; a full, progressing pipeline.

How we fix it

The diagnosis is the front end of the 10-week program — and a complete first engagement on its own. You leave with a ranked map of where the GTM breaks and a layout of how to fix it. If there's no fit, I'll tell you directly.

How we rebuild the system — six-block Fit to Scale program over 10 weeks

This is not sales theater.

We do not promise:

  • fully AI-automated pipelines
  • hypergrowth or '10x scaling'
  • guaranteed revenue

We deliver:

  • GTM clarity
  • market-fit direction and alignment
  • an executable, scalable GTM system fit to your product and industry

The goal is not to look scalable — the goal is to become scalable.

Start with clarity.

The 10-week Fit-to-Scale program is not a pitch call. It's a structured analysis of where your pipeline breaks, a layout of how to fix the misalignment, and a system to scale sales. If there's no fit, I'll tell you directly.

Book a GTM diagnosis
Dr. Denis Jung, founder of Fit to Scale

I'll show you where your pipeline breaks — and how to fix it.

Dr. Denis Jung

Founder, Fit to Scale

Fix the Pipeline

One more thing

Not sure where your GTM breaks?

A short self-diagnostic — the five symptoms and what each usually means.

Book a GTM diagnosis